Citadel Advisors’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-47,821
| Closed | -$17K | – | 4505 |
|
|
2016
Q3 | $17K | Sell |
47,821
-196,413
| -80% | -$69.8K | ﹤0.01% | 3474 |
|
|
2016
Q2 | $114K | Buy |
+244,234
| New | +$114K | ﹤0.01% | 2933 |
|
|
2016
Q1 | – | Sell |
-17,229
| Closed | -$25K | – | 4539 |
|
|
2015
Q4 | $25K | Sell |
17,229
-46,174
| -73% | -$67K | ﹤0.01% | 3578 |
|
|
2015
Q3 | $100K | Sell |
63,403
-16,760
| -21% | -$26.4K | ﹤0.01% | 3388 |
|
|
2015
Q2 | $136K | Sell |
80,163
-75,753
| -49% | -$129K | ﹤0.01% | 3166 |
|
|
2015
Q1 | $217K | Buy |
155,916
+139,663
| +859% | +$194K | ﹤0.01% | 3072 |
|
|
2014
Q4 | $25K | Buy |
16,253
+15,043
| +1,243% | +$23.1K | ﹤0.01% | 3548 |
|
|
2014
Q3 | $2K | Sell |
1,210
-41,250
| -97% | -$68.2K | ﹤0.01% | 3494 |
|
|
2014
Q2 | $130K | Sell |
42,460
-71,145
| -63% | -$218K | ﹤0.01% | 2933 |
|
|
2014
Q1 | $284K | Buy |
113,605
+91,270
| +409% | +$228K | ﹤0.01% | 2643 |
|
|
2013
Q4 | $111K | Buy |
22,335
+3,079
| +16% | +$15.3K | ﹤0.01% | 2624 |
|
|
2013
Q3 | $44K | Buy |
19,256
+8,771
| +84% | +$20K | ﹤0.01% | 2633 |
|
|
2013
Q2 | $23K | Buy |
+10,485
| New | +$23K | ﹤0.01% | 2624 |
|